Results 101 to 110 of about 10,258 (173)

Phase 1 multicenter study of the NKG2A targeting antibody S095029 as a single agent and in combination with anti-PD-1 in patients with advanced malignancies. [PDF]

open access: yesJ Immunother Cancer
Naing A   +11 more
europepmc   +1 more source

Dynamics of in vivo immune remodeling in Ph<sup>+</sup> all patients receiving frontline ponatinib and blinatumomab therapy. [PDF]

open access: yesBlood Cancer J
Peragine N   +14 more
europepmc   +1 more source

Peptide occupancy governs HLA-E checkpoint interactions enabling VISTA recognition of destabilized HLA-E conformers. [PDF]

open access: yesCommun Biol
Watters CR   +8 more
europepmc   +1 more source

NKG2A inhibition promotes NK cell-CD8<sup>+</sup> T cell interactions to improve anticancer immunity in ovarian carcinoma. [PDF]

open access: yesNat Commun
Lanickova T   +37 more
europepmc   +1 more source

Preferential engagement of the anti-inflammatory ATP/adenosine axis by HIV vaccine candidate with V1-deleted envelope in male rhesus macaques. [PDF]

open access: yesCell Rep Med
Silva de Castro I   +23 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy